Much like with the first antibiotics, the answer to the growing problem of infection control lies in understanding efficient natural anti-pathogenic mechanisms, borrowing their efficiency and transposing this efficiency into clinical practice.

In Nature, T-viruses called Bacteriophages fulfill the role of bacterial growth control. They are extremely specialized “predators” that only affect a set spectrum of pathogens.

We envisage the main advantages of Phage Therapy to be:

• lack of side effects - specific effect exclusively against targeted pathogenic spectrum
• effectiveness - visibly rapid effect in-vitro and in-vivo
• overcomes therapy failure due to resistance
• suitable for combination therapy to boost the effect of regular antibiotics and shorten therapy period
• no gene-technical process
  
  

These advantages should result in:

• Effective treatment of certain chronic and nosocomial infections (e.g. MRSA)...
• ...without burdening the patient with side effects